Clinical Trial Update: Open-Label Study of 18F-mFBG for Imaging Myocardial Sympathetic Innervation [Phase 1, Phase 2]

View source ↗

Summary

Open-label Phase 1/2 trial of the radiopharmaceutical 18F-mFBG for imaging myocardial sympathetic innervation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• [18F]-MFBG (18F-MFBG)

Snippet

Sponsor: Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) | Conditions: Cardiovascular Diseases | Phase 1, Phase 2 | Status: COMPLETED